| Size | Price | |
|---|---|---|
| 500mg | ||
| 1g | ||
| Other Sizes |
| Targets |
The primary molecular target of (Rac)-Apremilast D5 is phosphodiesterase 4 (PDE4), an enzyme that hydrolyzes cyclic AMP (cAMP). Inhibition of PDE4 increases intracellular cAMP levels, leading to downregulation of pro-inflammatory cytokines such as TNF-α, IL-17, and IL-23. This mechanism underlies the anti-inflammatory effects of apremilast in psoriasis and psoriatic arthritis.
|
|---|---|
| ln Vitro |
As a deuterated internal standard, (Rac)-Apremilast D5 is not used for its biological activity but for analytical quantification. In vitro, it is used in LC-MS/MS assays to quantify apremilast levels in plasma or tissue samples. The deuterium atoms provide a mass shift that allows differentiation from the non-deuterated analyte.
|
| ln Vivo |
In vivo data for (Rac)-Apremilast D5 are not applicable as it is an analytical standard. It is used to support pharmacokinetic studies of apremilast in animals and humans by providing accurate quantification of the drug in biological matrices.
|
| Enzyme Assay |
For in vitro bioanalytical assays, (Rac)-Apremilast D5 is used as an internal standard in LC-MS/MS. A known amount of the internal standard is added to biological samples (e.g., plasma) prior to protein precipitation or solid-phase extraction. The samples are then analyzed by LC-MS/MS, and the ratio of analyte to internal standard is used for quantification.
|
| Cell Assay |
In vitro cell experiments are not applicable for (Rac)-Apremilast D5 as it is an analytical standard.
|
| Animal Protocol |
In vivo animal protocols are not applicable for (Rac)-Apremilast D5 as it is an analytical standard. It is used in the analysis of samples from in vivo studies of apremilast.
|
| References |
Arthritis Res Ther.2015 Sep 15;17:249; |
| Molecular Formula |
C22H19D5N2O7S
|
|---|---|
| Molecular Weight |
465.53
|
| Exact Mass |
465.161
|
| CAS # |
1258597-61-3
|
| Related CAS # |
Apremilast;608141-41-9;Apremilast-d5;1258597-47-5
|
| PubChem CID |
49847737
|
| Appearance |
Typically exists as solid at room temperature
|
| LogP |
1.8
|
| tPSA |
128
|
| Hydrogen Bond Donor Count |
1
|
| Hydrogen Bond Acceptor Count |
7
|
| Rotatable Bond Count |
8
|
| Heavy Atom Count |
32
|
| Complexity |
825
|
| Defined Atom Stereocenter Count |
0
|
| SMILES |
[2H]C([2H])([2H])C([2H])([2H])OC1=C(C=CC(=C1)C(CS(=O)(=O)C)N2C(=O)C3=C(C2=O)C(=CC=C3)NC(=O)C)OC
|
| InChi Key |
IMOZEMNVLZVGJZ-RPIBLTHZSA-N
|
| InChi Code |
InChI=1S/C22H24N2O7S/c1-5-31-19-11-14(9-10-18(19)30-3)17(12-32(4,28)29)24-21(26)15-7-6-8-16(23-13(2)25)20(15)22(24)27/h6-11,17H,5,12H2,1-4H3,(H,23,25)/i1D3,5D2
|
| Chemical Name |
N-[2-[1-[4-methoxy-3-(1,1,2,2,2-pentadeuterioethoxy)phenyl]-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
May dissolve in DMSO (in most cases), if not, try other solvents such as H2O, Ethanol, or DMF with a minute amount of products to avoid loss of samples
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80: Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 :Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400  (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1481 mL | 10.7404 mL | 21.4809 mL | |
| 5 mM | 0.4296 mL | 2.1481 mL | 4.2962 mL | |
| 10 mM | 0.2148 mL | 1.0740 mL | 2.1481 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.